Literature DB >> 12881722

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

Chiara Zuccato1, Marzia Tartari, Andrea Crotti, Donato Goffredo, Marta Valenza, Luciano Conti, Tiziana Cataudella, Blair R Leavitt, Michael R Hayden, Tõnis Timmusk, Dorotea Rigamonti, Elena Cattaneo.   

Abstract

Huntingtin protein is mutated in Huntington disease. We previously reported that wild-type but not mutant huntingtin stimulates transcription of the gene encoding brain-derived neurotrophic factor (BDNF; ref. 2). Here we show that the neuron restrictive silencer element (NRSE) is the target of wild-type huntingtin activity on BDNF promoter II. Wild-type huntingtin inhibits the silencing activity of NRSE, increasing transcription of BDNF. We show that this effect occurs through cytoplasmic sequestering of repressor element-1 transcription factor/neuron restrictive silencer factor (REST/NRSF), the transcription factor that binds to NRSE. In contrast, aberrant accumulation of REST/NRSF in the nucleus is present in Huntington disease. We show that wild-type huntingtin coimmunoprecipitates with REST/NRSF and that less immunoprecipitated material is found in brain tissue with Huntington disease. We also report that wild-type huntingtin acts as a positive transcriptional regulator for other NRSE-containing genes involved in the maintenance of the neuronal phenotype. Consistently, loss of expression of NRSE-controlled neuronal genes is shown in cells, mice and human brain with Huntington disease. We conclude that wild-type huntingtin acts in the cytoplasm of neurons to regulate the availability of REST/NRSF to its nuclear NRSE-binding site and that this control is lost in the pathology of Huntington disease. These data identify a new mechanism by which mutation of huntingtin causes loss of transcription of neuronal genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881722     DOI: 10.1038/ng1219

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  331 in total

1.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

Review 2.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

3.  Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.

Authors:  Alexander W Bruce; Ian J Donaldson; Ian C Wood; Sally A Yerbury; Michael I Sadowski; Michael Chapman; Berthold Göttgens; Noel J Buckley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

4.  Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation.

Authors:  Xiaohua Su; Sei Kameoka; Susan Lentz; Sadhan Majumder
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Conversion of myoblasts to physiologically active neuronal phenotype.

Authors:  Yumi Watanabe; Sei Kameoka; Vidya Gopalakrishnan; Kenneth D Aldape; Zhizhong Z Pan; Frederick F Lang; Sadhan Majumder
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

6.  The enemy within: intronic miR-26b represses its host gene, ctdsp2, to regulate neurogenesis.

Authors:  Jinju Han; Ahmet M Denli; Fred H Gage
Journal:  Genes Dev       Date:  2012-01-01       Impact factor: 11.361

Review 7.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

8.  Inhibition of the Epigenetic Regulator REST Ameliorates Ischemic Brain Injury.

Authors:  Kahlilia C Morris-Blanco; TaeHee Kim; Mario J Bertogliat; Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Mol Neurobiol       Date:  2018-07-23       Impact factor: 5.590

Review 9.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 10.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.